Silymarin: An Effective Hepatoprotective Agent Against Diethylnitrosamine-Induced Hepatotoxicity in Rats

References

• Ahmed S, Rahman A, Mathur M, Athar M, Sultana S (2001): Antitumour promoting activity of Asteracantha longifolia. against experimental hepatocarcinogenesis in rats. Food Chem Toxicol l39: 19–28.
   Google Scholar
• Akintonwa DA (1985): The derivation of nitrosamines from some therapeutic amines in the human environment. Ecotocicol Environ Saf 9: 64–70.
   PubMed Web of Science ®Google Scholar
• Barbisan LF, Scolastici C, Miyamoto M, Salvadori DMF, Ribeiro LR, daEira AF, deCamargo JLV (2003): Effects of crude extracts of Agaricus blazei. on DNA damage and on rat liver carcinogenesis induced by diethylnitrosamine. Gen Mol Res 2: 295–308.
   PubMedGoogle Scholar
• Batakov EA (2001): Effect of Silybum marianum. oil and legalon on lipid peroxidation and liver antioxidant systems in rats intoxicated with carbon tetrachloride. Eksp Klin Farmakol 64: 53–55.
   PubMedGoogle Scholar
• Belmenthal M (1998): The Complete German Commission E Monograph: Therapeutic Guide to Herbal Medicine. Austin, American Botanical Counciland Boston,Integrative Medicine Communications, p. 163.
   Google Scholar
• Beuttner GR (1993): The peeking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys 300: 535–543.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee R, Sil PC (2006): The protein fraction of Phyllanthus niruri. plays a protective role against acetaminophen induced hepatic disorder via its antioxidant properties. Phytother Res 20: 595–601.
   PubMed Web of Science ®Google Scholar
• Choksi S, Patel SS, Saluja AK (2000): Silymarin—a promising herbal hepatoprotective drug. Ind Drugs 37: 566–569.
   Google Scholar
• Das S (1994): Vitamin E in the genesis and prevention of cancer. A review. Acta Oncol 33: 615–619.
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA (2006): Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo. performance. Int J Pharmacy 319: 121–129.
   PubMed Web of Science ®Google Scholar
• Feher J, Deak G, Muzes G, Lang I, Niederland V, Nekam K (1989): Liver protection action of silymarin therapy in chronic alcoholic liver diseases. Orv Hetil 130: 2723–2727.
   PubMedGoogle Scholar
• Flora K, Hahn M, Rosen H, Benner K (1998): Milk thistle (Silybum marianum.) for the therapy of liver diseases. Am J Gastroenterol 93: 139–143.
   PubMed Web of Science ®Google Scholar
• Fraschini F, Demartini G, Esposti D (2002): Pharmacology of silymarin. Clin Drug Invest 22: 51–65.
   Web of Science ®Google Scholar
• Fridovich I (1986): Superoxide dismutases. Adv Enzymol 58: 61–97.
   PubMedGoogle Scholar
• Goldsworthy TL, Hanigan MH (1986): Models of hepatocarcinogenesis in the rat—contrast and comparisons. CRC Crit Rev Toxicol 17: 61–89.
   Web of Science ®Google Scholar
• Gonzalez-Correa JA, de la Cruz JP, Gordillo J, Urena I, Redondo L, Sanchez de la Cuesta F (2002): Effects of silymarin MZ-80 on hepatic oxidative stress in rats with biliary obstruction. Pharmacology 64: 18–27.
   PubMed Web of Science ®Google Scholar
• Huseby NE, Ingebretsen OC (1993): The level of γ-glutamyltransferase in serum, effect of carbohydrate heterogeneity on clearance rate. Scand J Clin Lab Invest Suppl 215: 93–100.
   PubMedGoogle Scholar
• IARC (1972): Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 1. Lyon, International Agency for Research on Cancer, pp. 107–124.
   Google Scholar
• Jose JK, Kuttan R, Bhattacharaya RK (1998): Effect of Emblica officinalis. extract on hepatocarcinogenesis and carcinogen metabolism. J Clin Biochem Nutr 25: 31–39.
   Web of Science ®Google Scholar
• King J (1965a): The phosphohydrolases—acid and alkaline phosphatases. In: Practical Clinical Enzymology. London, D. Van Nostrand Co Ltd., pp. 191–208.
   Google Scholar
• King J (1965b): The dehydrogenase (or) oxidoreductase—Lactate dehydrogenase. In: Practical Clinical Enzymology. London, D. Van Nostrand Co Ltd., pp. 83–93.
   Google Scholar
• Kren V, Walterova D (2005): Silybin and silymarin—new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149: 29–41.
   PubMedGoogle Scholar
• Liao DJ, Blanck A, Eneroth P, Gustafsson JA, Hallstrom IP (2001): Diethylnitrosamine causes pituitary damage, disturbs hormone levels and reduces sexual dimorphism of certain liver functions in the rat. Environ Health Perspect 109: 943–947.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
   PubMed Web of Science ®Google Scholar
• Malloy HT, Evelyn KA (1937): The determination of bilirubin with photoelectric colorimeter. J Biol Chem 119: 481–490.
   Google Scholar
• Marklund S, Marklund G (1974): Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469–474.
   PubMedGoogle Scholar
• Muriel P, Garciapina T, Perez-Alvarez V, Mourelle M (1992): Silymarin protects against paracetamol induced lipid peroxidation and liver damage. J Appl Toxicol 12: 439–442.
   PubMed Web of Science ®Google Scholar
• Muriel P, Mourelle M (1990): Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 10: 275–279.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K (1979): Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–358.
   PubMed Web of Science ®Google Scholar
• Omaye ST, Turnbull JD, Sauberlich HE (1979): Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62: 1–11.
   Google Scholar
• Percy ME (1984): Catalase: An old enzyme with a new role? Can J Biochem Cell Biol 62: 1006–1014.
   PubMedGoogle Scholar
• Pitot H, Campbell H, Maronpot R, Bawa N, Rizvi T, Xu YH, Sargent L, Dragan Y, Pyron M (1989): Critical parameters in the quantitation of the stages of initiation, promotion and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 17: 594–612.
   PubMedGoogle Scholar
• Rosalki SB, Rau D (1972): Serum γ-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 39: 41–47.
   PubMed Web of Science ®Google Scholar
• Saller R, Meier R, Brignoli R (2001): The use of silymarin in the treatment of liver diseases. Drugs 61: 2035–2063.
   PubMed Web of Science ®Google Scholar
• Sallie R, Tredger JM, Willam R (1991): Drugs and the liver. Biopharm Drug Dispos 12: 251–259.
   PubMed Web of Science ®Google Scholar
• Sinha AK (1972): Colorimetric assay of catalase. Anal Biochem 47: 389–394.
   PubMed Web of Science ®Google Scholar
• Varley H, Gowenlock AH, Bell M (1976): In: Practical Clinical Biochemistry, Vol. II, Hormones, Vitamins, Drugs and Poisons, 5th ed. London, William Heinemann Medical Books Ltd, pp. 222–223.
   Google Scholar
• Vasudevan DM, Sreekumari S (2001): In: Text Book of Biochemistry for Medical Students, 3rd ed. New Delhi, Jaypee Brothers Medical Publishers (P) Ltd, p. 271.
   Google Scholar
• Viani P, Cervato G, Fiorilli A, Cestaro B (1991): Age-related differences in synaptosomal peroxidative damage and membrane properties. J Neurochem 56: 253–258.
   PubMed Web of Science ®Google Scholar
• Vitaglione P, Morisco F, Caporaso N, Fogliano V (2004): Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr 44: 575–586.
   PubMed Web of Science ®Google Scholar
• Wooten IDP (1964): In: Microanalysis in Medical Biochemistry. London, J & A Churchill Ltd, pp. 101–103.
   Google Scholar
• Yoshikawa M, Murakami T, Kishi A, Kageura T, Matsuda H (2001): Medicinal flowers III. Marigold (I): Hypoglycaemic, gastric emptying inhibitory and gastro protective principles and new oleane type triterpene oligoglycosides, calendasaponins A, B, C and D from Egyptian Calendula officinalis.. Chem Pharm Bull 49: 863–870.
   PubMed Web of Science ®Google Scholar
• Zielinska-Przyjemska M, Wiktorowicz K (2006): An in vitro. study of the protective effect of the flavonoid silydianin against reactive oxygen species. Phytother Res 20: 115–119.
   PubMed Web of Science ®Google Scholar